Signs and Symptoms, Respiratory D012818

Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Signs and Symptoms, Respiratory

Description

Respiratory system manifestations of diseases of the respiratory tract or of other organs.   MeSH

Hierarchy View

Subtype Terms (19)

Apnea
19 drugs (15 approved, 4 experimental)

Brief, Resolved, Unexplained Event
 

Cheyne-Stokes Respiration
2 drugs (1 approved, 1 experimental)

Cough
123 drugs (56 approved, 67 experimental)

Dyspnea
42 drugs (30 approved, 12 experimental)

Epistaxis
19 drugs (16 approved, 3 experimental)

Hemoptysis
7 drugs (6 approved, 1 experimental)

Hoarseness
2 drugs (1 approved, 1 experimental)

Hypercapnia
8 drugs (7 approved, 1 experimental)

Hyperoxia
3 drugs (2 approved, 1 experimental)

Hyperventilation
1 approved drug

Hypocapnia
1 approved drug

Hypoventilation
1 approved drug

Hypoxia
75 drugs (54 approved, 21 experimental)

Mouth Breathing
 

Respiratory Sounds
25 drugs (18 approved, 7 experimental)

Rhinorrhea
5 drugs (4 approved, 1 experimental)

Sneezing
7 drugs (5 approved, 2 experimental)

Tachypnea
2 approved drugs


Phase 3 Indicated Drugs (2)

Phase 2 Indicated Drugs (1)


Organization Involved with Phase 4 Indications (4)

Organization Involved with Phase 2 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.